Name
Capella University
NURS-FPX 4060 Practicing in the Community to Improve Population Health
Prof. Name
Date
Hello, my name is ________, and I am a community nurse. I am pleased to welcome you to today’s session. The focus of our discussion is Human Papillomavirus (HPV), a widely prevalent sexually transmitted infection. This session aims to provide insight into HPV, its prevalence, impact, and an evidence-based health promotion plan designed to improve patient outcomes and awareness.
What is HPV?
Human Papillomavirus (HPV) is a group of viruses that primarily infect the skin and mucous membranes. To date, over 200 types of HPV have been identified, with approximately 40 of them transmitted sexually. These high-risk types can infect the genital region, oral cavity, and throat. HPV is recognized as the most common sexually transmitted infection, affecting nearly all sexually active individuals at some stage in their lives (Soheili et al., 2021).
HPV infection is more likely among individuals with multiple sexual partners, polygamous relationships, men who have sex with men, unprotected sexual encounters, and, to a lesser extent, those with substance use issues. Interestingly, infection is often asymptomatic, meaning individuals may not realize they carry the virus until complications arise, such as genital warts or HPV-related cancers (El-Zein et al., 2019).
Why is awareness important?
HPV infections can remain latent for years or even decades before symptoms appear. Although many infections resolve spontaneously, high-risk HPV types pose serious health threats. According to the World Health Organization (WHO), these types can lead to cancers and other significant health issues (WHO, 2023). Early awareness and preventive measures are therefore critical for reducing HPV-related morbidity and mortality.
Who is affected by HPV and how common is it?
HPV affects millions annually. In the United States, an estimated 42 million people were infected in 2018, with approximately 13 million new infections occurring each year (HPV, 2023). Infection rates vary based on age, gender, socio-economic status, geographic location, and HPV type. Individuals aged 15–25 are most susceptible, accounting for around 75% of new infections (Clarke et al., 2021).
How does prevalence differ between genders?
Women tend to be more frequently affected than men, with cervical cancer being the primary manifestation in women, while HPV-related throat cancers are more common in men. Annually, 21,000 women and 15,000 men are infected, with roughly 4,000 female deaths due to HPV-related complications (HPV, 2023).
What other factors influence prevalence?
| Factor | Observation |
|---|---|
| Socioeconomic Status | Middle- and low-income individuals show higher HPV prevalence than high-income groups. |
| Geographic Location | Southern and Midwestern U.S. regions have higher infection rates compared to northern regions. |
| Age | Teens to young adults (15–25 years) are most affected. |
| Gender | Women are more frequently infected; men have higher rates of HPV-related throat cancers. |
Globally, cervical cancer is the fourth leading cause of cancer-related death, causing approximately 342,000 deaths in 2020 (WHO, 2023). Oral HPV prevalence is 5.0% among men and 3.6% among women (Yu et al., 2023).
How does HPV affect health?
The consequences of HPV extend beyond infection. High-risk HPV types can lead to cervical cancer, genital warts, and other malignancies affecting the vagina, vulva, penis, anus, mouth, and throat (Kombe et al., 2021). Beyond physical health, HPV also has substantial psychological, social, and financial implications.
Psychologically, HPV-related diagnoses can trigger anxiety, guilt, and stress due to stigma surrounding sexually transmitted infections (Chadwick et al., 2022). Social isolation may result from unacceptability in familial or community settings, impacting the individual’s ability to access support. Financially, the cost of screening, vaccination, and cancer treatment may be burdensome, particularly for socioeconomically disadvantaged individuals (Chesson et al., 2021).
What strategies help reduce the impact?
Vaccination, education, counseling, and access to community-based healthcare services are key to mitigating the disease’s impact. Nurses play a pivotal role in raising awareness, promoting screenings, and facilitating access to preventive care (Luttjeboer et al., 2023).
How can nurses contribute to HPV prevention?
Nurses and healthcare providers are instrumental in promoting HPV awareness through education and collaboration. Educational strategies, including pamphlets, workshops, and online sessions, can dispel myths and increase knowledge about HPV, its risks, and preventive measures (Rodríguez et al., 2019).
What community-based interventions are effective?
Schools and youth organizations are critical venues for vaccination education and safe sexual practice awareness. Counseling parents and adolescents, offering free screenings, and providing vaccination services at community-based clinics can prevent HPV-related cancers (Pathak et al., 2022; Bastani et al., 2021).
What are the SMART goals for HPV prevention?
SMART goals—Specific, Measurable, Achievable, Relevant, and Time-bound—provide structure for health promotion plans (Bailey, 2019). Table 1 outlines a practical SMART plan for a patient, Maria, who faces physical, emotional, social, and financial challenges related to HPV.
| Goal | Description | Timeline |
|---|---|---|
| Reduce financial burden | Reduce expenses by 60% through awareness of insurance and assistance programs | 6 months |
| Increase HPV knowledge | Attend six workshops (in-person and virtual) to learn about HPV and dispel myths | 3 months |
| Enhance social support | Connect with support groups to mitigate stigma and isolation | Ongoing |
| Improve emotional well-being | Participate in weekly therapy sessions to develop coping mechanisms | 3 months |
Educational interventions improve knowledge, reduce misconceptions, and empower patients. Maria’s participation in workshops and online support groups increased her HPV literacy, helped her access community-based services, and enhanced her emotional resilience. Therapy sessions provided coping strategies for stress and depression, improving her overall quality of life (Santos et al., 2022).
How can educational sessions be improved?
| Improvement | Strategy |
|---|---|
| Cultural sensitivity | Tailor messaging to different cultural backgrounds |
| Audience reach | Expand to schools, colleges, and online platforms |
| Learning evaluation | Use quizzes, polls, and discussion sessions |
| Multilingual resources | Ensure materials are available in multiple languages |
| Integration with healthcare | Collaborate with primary care professionals for consistent education |
| Peer support | Include testimonials and experiences from peers |
| Influencer engagement | Use social media and credible figures to reinforce messages |
How does the plan align with national health objectives?
The Healthy People 2030 initiative aims to vaccinate 90% of 15-year-old girls, screen 70% of women aged 35–45 for cervical cancer, and treat 90% of HPV-related diagnoses (Vorsters et al., 2022; U.S. Department of Health and Human Services, 2023). Maria’s plan aligns with these objectives by promoting preventive care, health literacy, and social support. Culturally tailored interventions address health inequities, particularly for minority groups like Maria (Sundaram et al., 2019).
Which policies support HPV prevention?
The Patient Protection and Affordable Care Act (ACA) provides coverage for preventive services, promoting equity and affordability (Raymond et al., 2021). Medicaid supports low- and middle-income individuals in accessing screenings and vaccinations. These policies complement Maria’s education, counseling, therapy, and community engagement to achieve holistic health outcomes.
How can educational sessions be enhanced?
Future improvements include culturally tailored messaging, expanding online workshops, integrating quizzes and polls, providing multilingual materials, incorporating peer support, and collaborating with primary care providers (Wong et al., 2020; Olusanya et al., 2021; Leung et al., 2019). Influencer participation can also increase engagement and credibility in promoting HPV preventive measures (Lewis et al., 2021).
HPV is a common sexually transmitted infection, predominantly affecting individuals aged 15–25. High-risk HPV types can cause various cancers, impacting physical, emotional, social, and financial well-being. A health promotion plan involving education, vaccinations, screenings, counseling, and community support can prevent HPV-related complications and improve quality of life. Aligning these strategies with Healthy People 2030 goals ensures effective prevention and management, demonstrating the importance of structured, evidence-based interventions.
Bailey, R. (2019). Goal setting and action planning for health behavior change. American Journal of Lifestyle Medicine, 13(6), 615–618. https://doi.org/10.1177/1559827617729634
Bastani, R., Glenn, B. A., Singhal, R., Crespi, C. M., Nonzee, N. J., Tsui, J., … Taylor, V. M. (2021). Increasing HPV vaccination among low-income, ethnic minority adolescents: Effects of a multicomponent system intervention through a county health department hotline. Cancer Epidemiology Biomarkers & Prevention, 31(1), 175–182. https://doi.org/10.1158/1055-9965.epi-20-1578
Chadwick, V., Bennett, K. F., McCaffery, K. J., Brotherton, J. M. L., & Dodd, R. H. (2022). Psychosocial impact of testing human papillomavirus positive in Australia’s human papillomavirus‐based cervical screening program: A cross‐sectional survey. Psycho-Oncology, 31(7), 1110–1119. https://doi.org/10.1002/pon.5897
Chesson, H. W., Laprise, J.-F., Brisson, M., Martin, D., Ekwueme, D. U., & Markowitz, L. E. (2021). The estimated lifetime medical cost of diseases attributable to human papillomavirus infections acquired in 2018. Sexually Transmitted Diseases. https://doi.org/10.1097/olq.0000000000001379
Clarke, M. A., Risley, C., Stewart, M. W., Geisinger, K. R., Hiser, L. M., Morgan, J. C., … Wentzensen, N. (2021). Age-specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort. Cancer Medicine, 10(23), 8641–8650. https://doi.org/10.1002/cam4.4340
El-Zein, M., Coutlée, F., Tellier, P.-P., Roger, M., Franco, E. L., & Burchell, A. N. (2019). Human papillomavirus infection and transmission among couples through heterosexual activity (HITCH) cohort study: Protocol. JMIR Research Protocols, 8(1), e11284. https://doi.org/10.2196/11284
Hirth, J. M., Kuo, Y.-F., Starkey, J. M., Rupp, R. E., Laz, T. H., Rahman, M., & Berenson, A. B. (2019). Regional variations in human papillomavirus prevalence across time in NHANES (2003–2014). Vaccine, 37(30), 4040–4046. https://doi.org/10.1016/j.vaccine.2019.06.001
HPV. (2023, March). National Foundation for Infectious Diseases. https://www.nfid.org/infectious-disease/hpv/
Kombe, A. J., Li, B., Zahid, A., Mengist, H. M., Bounda, G.-A., Zhou, Y., & Jin, T. (2021). Epidemiology and burden of human papillomavirus and related diseases. Frontiers in Public Health, 8, 552028. https://doi.org/10.3389/fpubh.2020.552028
Luttjeboer, J., Simons, J. J. M., Westra, T. A., Wilschut, J., Boersma, C., Postma, M. J., & van. (2023). An updated analysis of the impact of HPV vaccination based on long-term effectiveness in the Netherlands. Infectious Diseases and Therapy, 12(8), 2135–2145. https://doi.org/10.1007/s40121-023-00851-9
Rodríguez, L., Barrios, M., Pachón, C., & Lugo, E. (2019). Educational intervention on human papillomavirus in university students. Indian Journal of Community Medicine, 44(3), 213. https://doi.org/10.4103/ijcm.ijcm_247_18
Santos, P. D., Melly, P., Hilfiker, R., Giacomino, K., Perruchoud, E., Verloo, H., & Pereira, F. (2022). Effectiveness of educational interventions to increase skills in evidence-based practice among nurses: The EDITCare systematic review. Healthcare (Basel), 10(11), 2204. https://doi.org/10.3390/healthcare10112204
Soheili, M., Keyvani, H., Soheili, M., & Nasseri, S. (2021). Human papillomavirus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment. Medical Journal of the Islamic Republic of Iran. https://doi.org/10.47176/mjiri.35.65
Sundaram, N., Voo, T. C., & Tam, C. C. (2019). Adolescent HPV vaccination: Empowerment, equity, and ethics. Human Vaccines & Immunotherapeutics, 16(8), 1835–1840. https://doi.org/10.1080/21645515.2019.1697596
U.S. Department of Health and Human Services. (2023). Healthy People 2030. https://health.gov/healthypeople
Vorsters, A., Bosch, F. X., Poljak, M., Waheed, D.-N., Stanley, M., & Garland, S. M. (2022). HPV prevention and control – The way forward. Preventive Medicine, 156, 106960. https://doi.org/10.1016/j.ypmed.2022.106960
WHO. (2023, November 17). Cervical cancer. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
Yu, S., Zhu, Y., He, H., Hu, Y., Zhu, X., Diao, W., Li, S., Shan, G., & Chen, X. (2023). Prevalence and risk factors of oral human papillomavirus infection among healthy adults in Hebei, China. BMC Infectious Diseases, 23(1), 773. https://doi.org/10.1186/s12879-023-08759-y
